Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Hormonal risk factors and invasive epithelial ovarian cancer risk by parity.

Bodelon C, Wentzensen N, Schonfeld SJ, Visvanathan K, Hartge P, Park Y, Pfeiffer RM.

Br J Cancer. 2013 Aug 6;109(3):769-76. doi: 10.1038/bjc.2013.344. Epub 2013 Jul 2.

2.

Anthropometry and the risk of epithelial ovarian cancer.

Greer JB, Modugno F, Ness RB, Allen GO.

Cancer. 2006 May 15;106(10):2247-57.

3.

In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk.

Stewart LM, Holman CD, Aboagye-Sarfo P, Finn JC, Preen DB, Hart R.

Gynecol Oncol. 2013 Feb;128(2):260-4. doi: 10.1016/j.ygyno.2012.10.023. Epub 2012 Oct 29.

PMID:
23116937
4.

Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness.

Poole EM, Merritt MA, Jordan SJ, Yang HP, Hankinson SE, Park Y, Rosner B, Webb PM, Cramer DW, Wentzensen N, Terry KL, Tworoger SS.

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):429-37. doi: 10.1158/1055-9965.EPI-12-1183-T. Epub 2013 Jan 10.

5.

Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.

Pfeiffer RM, Park Y, Kreimer AR, Lacey JV Jr, Pee D, Greenlee RT, Buys SS, Hollenbeck A, Rosner B, Gail MH, Hartge P.

PLoS Med. 2013;10(7):e1001492. doi: 10.1371/journal.pmed.1001492. Epub 2013 Jul 30.

6.

Reproductive factors and incidence of epithelial ovarian cancer: a Norwegian prospective study.

Albrektsen G, Heuch I, Kvåle G.

Cancer Causes Control. 1996 Jul;7(4):421-7.

PMID:
8813430
7.

Parity, contraception, infertility, and the risk of epithelial ovarian cancer.

Risch HA, Marrett LD, Howe GR.

Am J Epidemiol. 1994 Oct 1;140(7):585-97.

PMID:
7942759
8.

Association of parity and ovarian cancer risk by family history of breast or ovarian cancer in a population-based study of postmenopausal women.

Vachon CM, Mink PJ, Janney CA, Sellers TA, Cerhan JR, Hartmann L, Folsom AR.

Epidemiology. 2002 Jan;13(1):66-71.

PMID:
11805588
9.

Ovarian stimulation and borderline ovarian tumors: a case-control study.

Mosgaard BJ, Lidegaard O, Kjaer SK, Schou G, Andersen AN.

Fertil Steril. 1998 Dec;70(6):1049-55.

PMID:
9848294
10.

An aggregated analysis of hormonal factors and endometrial cancer risk by parity.

Schonfeld SJ, Hartge P, Pfeiffer RM, Freedman DM, Greenlee RT, Linet MS, Park Y, Schairer C, Visvanathan K, Lacey JV Jr.

Cancer. 2013 Apr 1;119(7):1393-401. doi: 10.1002/cncr.27909. Epub 2012 Dec 20.

11.

Hormone-related risk factors and postmenopausal breast cancer among nulliparous versus parous women: An aggregated study.

Schonfeld SJ, Pfeiffer RM, Lacey JV Jr, Berrington de González A, Doody MM, Greenlee RT, Park Y, Schairer C, Schatzkin A, Sigurdson AJ, Hartge P, Visvanathan K.

Am J Epidemiol. 2011 Mar 1;173(5):509-17. doi: 10.1093/aje/kwq404. Epub 2011 Jan 25.

12.

Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.

Rasmussen EL, Hannibal CG, Dehlendorff C, Baandrup L, Junge J, Vang R, Kurman RJ, Kjaer SK.

Gynecol Oncol. 2017 Mar;144(3):571-576. doi: 10.1016/j.ygyno.2017.01.002. Epub 2017 Jan 17.

PMID:
28108026
13.

Infertility, fertility drugs, and invasive ovarian cancer: a case-control study.

Mosgaard BJ, Lidegaard O, Kjaer SK, Schou G, Andersen AN.

Fertil Steril. 1997 Jun;67(6):1005-12.

PMID:
9176436
14.

Reproductive and hormonal factors in association with ovarian cancer in the Netherlands cohort study.

Braem MG, Onland-Moret NC, van den Brandt PA, Goldbohm RA, Peeters PH, Kruitwagen RF, Schouten LJ.

Am J Epidemiol. 2010 Nov 15;172(10):1181-9. doi: 10.1093/aje/kwq264. Epub 2010 Sep 22.

15.

Identifying post-menopausal women at elevated risk for epithelial ovarian cancer.

Urban N, Hawley S, Janes H, Karlan BY, Berg CD, Drescher CW, Manson JE, Palomares MR, Daly MB, Wactawski-Wende J, O'Sullivan MJ, Thorpe J, Robinson RD, Lane D, Li CI, Anderson GL.

Gynecol Oncol. 2015 Nov;139(2):253-60. doi: 10.1016/j.ygyno.2015.08.024. Epub 2015 Sep 3.

16.

Risk factors for epithelial ovarian cancer in Japan - results from the Japan Public Health Center-based Prospective Study cohort.

Weiderpass E, Sandin S, Inoue M, Shimazu T, Iwasaki M, Sasazuki S, Sawada N, Yamaji T, Tsugane S.

Int J Oncol. 2012 Jan;40(1):21-30. doi: 10.3892/ijo.2011.1194. Epub 2011 Sep 8.

PMID:
21904774
17.

Risk factors for epithelial ovarian cancer by histologic subtype.

Gates MA, Rosner BA, Hecht JL, Tworoger SS.

Am J Epidemiol. 2010 Jan 1;171(1):45-53. doi: 10.1093/aje/kwp314. Epub 2009 Nov 12.

18.

Physical activity in different periods of life, sedentary behavior, and the risk of ovarian cancer in the NIH-AARP diet and health study.

Xiao Q, Yang HP, Wentzensen N, Hollenbeck A, Matthews CE.

Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2000-8. doi: 10.1158/1055-9965.EPI-13-0154. Epub 2013 Aug 21.

19.

Type II diabetes mellitus and the incidence of epithelial ovarian cancer in the cancer prevention study-II nutrition cohort.

Gapstur SM, Patel AV, Diver WR, Hildebrand JS, Gaudet MM, Jacobs EJ, Campbell PT.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2000-5. doi: 10.1158/1055-9965.EPI-12-0867. Epub 2012 Aug 31.

20.

Multiple births and risk of epithelial ovarian cancer.

Whiteman DC, Murphy MF, Cook LS, Cramer DW, Hartge P, Marchbanks PA, Nasca PC, Ness RB, Purdie DM, Risch HA.

J Natl Cancer Inst. 2000 Jul 19;92(14):1172-7.

PMID:
10904091

Supplemental Content

Support Center